🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

RFK Jr. on the Hill today: “My vision is that every American is wearing a wearable within 4 years.” Says $80/month wearable can achieve similar results as Ozempic. Exploring ways to help pay for.

Exclusive: FDA's Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say My latest — endpoints.news/sources-fda-ch…

NEW: Hims won’t back down from selling copycat weight-loss shots after Novo Nordisk abruptly ended its distribution partnership. “There’s just no way in hell we’re going to cave on that," CEO andrewdudum told Bloomberg. More here from me + devin leonard: bloomberg.com/news/articles/…

Novo Nordisk split puts Hims & Hers future in question yahoo.trib.al/2QBF5e2 by Anjalee Khemlani

China is a real threat to US biotech innovation: EY life science expert yahoo.trib.al/xdszarQ by Anjalee Khemlani

.Elaine Chen reported earlier this month that fmr employees feel Novo Nordisk has been overly cautious in the obesity race. Now, Elaine has a great follow-up, where execs acknowledge their past conservative approach and map out the future. statnews.com/2025/06/25/nov…

NIH halts grant terminations ‘effective immediately,’ email says. Scoop from anil oza statnews.com/2025/06/25/nih…

The leader of UnitedHealth’s Optum Health care delivery unit has left the role, an early indication of management changes under Stephen Hemsley, UnitedHealth’s new CEO bloomberg.com/news/articles/…

Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes and weight-loss drugs in China due to local competition, a senior executive said. reut.rs/4kcvzTl reut.rs/4kcvzTl

reuters.com/business/healt…

The Affordable Care Act survives another trip to SCOTUS. Health insurers will continue to cover top-graded preventive services for free, but RFK (and other future HHS secretaries) have a lot of power over the independent body that grades those services. statnews.com/2025/06/27/sup…

US health officials met with Walmart, Amazon and other retailers as part of an effort to help Americans get their medicines more directly from companies that make them, according to people familiar with the talks bloomberg.com/news/articles/… via Bloomberg

How Novo Nordisk misread the US market for its weight loss sensation reuters.com/sustainability… $NVO

The pharma industry's top lobbies are walking a tightrope as they faces major changes to vaccine regulation, a mega tax-and-spending bill, and drug pricing policies that all stand to threaten their clout in Washington. W/ Kate Ackley Zeller news.bloomberglaw.com/health-law-and…

The British government and the pharmaceutical industry remain far apart in a dispute over drug pricing that has delayed publication of a long-pending plan for the UK life sciences sector. reut.rs/3TmrDVa reut.rs/3TmrDVa

For the few years I've been covering jobs reports, and one sector typically rises above the rest, quietly hiring by the thousands: Health care. How taking care of humans became the biggest employer in America, and what it means for the rest of us. nytimes.com/interactive/20…

Hospitals, pharma, doctors, medical devices, health insurers, PBMs — the entire health care industry has crushed working households through higher prices and out-of-pocket spending, to the point that health care is a bigger expense than a mortgage. x.com/lydiadepillis/…

How the tax-cut bill that’s headed to Trump’s desk would upend health care statnews.com/2025/07/03/tru…

Health savings accounts get small tweaks in tax bill finance.yahoo.com/news/health-sa… via Kerry Hannon

A GPT-powered medical device certified in Europe raises questions about generative AI in health care trib.al/0UrCsX4